• Skip to main content
  • Skip to main content
Choose which site to search.
University of Arkansas for Medical Sciences Logo University of Arkansas for Medical Sciences
Research and Innovation: Office of Research Compliance
  • UAMS Health
  • Jobs
  • Giving
  • Compliance Education Program
    • Advanced Certified Research Specialist Program
      • Advanced Certified Research Specialist Program Requirements
      • Advanced Certified Research Specialist Registration
    • Certified Research Specialist Program
      • Bonny Hope Wallace Award for Excellence in Human Subject Research
      • Certified Research Specialist Program Proficiency Exam
      • Certified Research Specialist Program Registration
      • Certified Research Specialist Program Requirements
      • Maintaining Certification
    • Educational Resources
    • Forms
      • General Information About the Certified Research Specialist Program
    • Good Clinical Practice Training
    • HIPAA Training
    • Human Subject Protection Training (CITI)
    • Responsible Conduct of Research Training
    • Upcoming Advanced Certified Research Specialist Courses
    • Upcoming Certified Research Specialist Courses
  • Resources and Tools
    • Non-Human Research Use of DEA Controlled Substances
    • Setting Up Studies and/or Research Staff
      • Human Subject Protection Training (CITI)
    • Tools and Templates
      • Regulatory Binders
      • Subject Study File and Source Documentation
  • Compliance Reviews
    • New Investigation Consult and Education Reviews
    • Selection for Review
    • The Review Process
  • Reporting Research Concerns
    • Compliance Hotline FAQs
    • Research Misconduct
  • News
  • Contact Us
  • Helpful Links
  1. University of Arkansas for Medical Sciences
  2. Research and Innovation
  3. Office of Research Compliance
  4. News
  5. A Top N.Y.U. Researcher Dismissed from Research Study

A Top N.Y.U. Researcher Dismissed from Research Study

Alexander Neumeister, M.D., former head of the molecular imaging program at New York University (NYU) School of Medicine, conducted psychiatric research without providing appropriate oversight, states a Feb. 6 warning letter issued by the Food and Drug Administration (FDA), which cited a host of problems uncovered in two protocols during an inspection from July 16-Aug. 5 of last year. Among the issues were falsification of records and failure to confirm “the accuracy of a diagnosis for 13 of the 14 enrolled subjects.”

The industry-sponsored research involved subjects with post-traumatic stress disorder, according to an investigation by The New York Times (NYT), which quoted Charles Marmar, chairman of the psychiatry department, who confirmed that Neumeister had resigned as a result of the issues and that a total of eight psychiatric trials were terminated. Neumeister’s attorney told the NYT there was a difference of opinion as to the seriousness of the problems. Both Marmar and Neumeister’s attorney said no subjects were harmed, according to the NYT. The publication also interviewed a female participant who blogged about her experiences, including having to stop her medications five times due to “false starts” of the research.

Link to NYT article: http://www.nytimes.com/2016/06/28/health/nyu-cannabis-ptsd-psychiatry.html

Link to warning letter: http://www.fda.gov/ICECI/EnforcementActions/WarningLetters/2016/ucm493086.htm

Posted by uamsonline on July 5, 2016

Filed Under: News

University of Arkansas for Medical Sciences LogoUniversity of Arkansas for Medical SciencesUniversity of Arkansas for Medical Sciences
Mailing Address: 4301 West Markham Street, Little Rock, AR 72205
Phone: (501) 686-7000
  • Facebook
  • Twitter
  • Instagram
  • YouTube
  • LinkedIn
  • Pinterest
  • Disclaimer
  • Terms of Use
  • Privacy Statement

© 2023 University of Arkansas for Medical Sciences